Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
Clearmind Medicine Inc. has filed a European patent application for innovative psychedelic compounds aimed at treating PTSD and other mental health disorders, strengthening its intellectual property position in Europe. This move aligns with a new U.S. executive order promoting the advancement of psychedelic-based therapies, highlighting significant…